References
- Adler, M. W., Geller, E. B., Chen, X., Rogers, T. J. (2006). Viewing chemokines as a third major system of communication in the brain. AAPS J., 7(4), E865-E870.
- Almofti, A., Uchida, D., Begum, N. M., Tomizuka, Y., Iga, H., Yoshida, H., Sato, M. (2004). The clinicopathological significance of the expression of CXCR4 protein in oral squamous cell carcinoma. Int. J. Oncol., 25(1), 65-71.
- Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J., Springer, T. A. (1996). The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature, 382, 829-833.
- Campbell, M. J. (1995). Lipofection reagents prepared by a simple ethanol injection technique. BioTechniques, 18(6), 1027-1032.
- Crump, M., Gong, J., Loetscher, P., Rajarathnam, K., Amara, A., Arenzana-Seisdedos, F., Virelizier, J., Baggiolini, M., Sykes, B., Clark-Lewis, I. (1997). Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO Journal, 16(23), 6996-7007.
- Darash-Yahana, M., Pikarsky, E., Abramovitch, R., Zeira, E., Pal, B., Karplus, R., Beider, K., Avniel, S., Kasem, S., Galun, E., Peled, A. (2004). Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB J., 18(11), 1240-1242.
- Doranz, B. J., Orsini, M. J., Turner, J. D., Hoffman, T. L., Berson, J. F., Hoxie, J. A., Peiper, S. C., Brass, L. F., Doms, R. W. (1999). Identification of CXCR4 domains that support coreceptor and chemokine receptor functions. J. Virol., 73(4), 2752-2761.
- Fujii, N., Nakashima, H., Tamamura, H. (2003). The therapeutic potential of CXCR4 antagonists in the treatment of HIV. Expert Opin. Investig. Drugs, 12(2), 185-195.
- Gupta, S. K., Pillarisetti, K. (1999). Cutting edge: CXCR4-Lo: molecular cloning and functional expression of a novel human CXCR4 splice variant. J. Immunol., 163(5), 2368-2372.
- Heesen, M., Berman, M. A., Benson, J. D., Gerard, C., Dorf, M. E. (1996). Cloning of the mouse fusin gene, homologue to a human HIV-1 co-factor. J. Immunol., 157(12), 5455-5460.
- Holm, N. T., Byrnes, K., MacDonald, M., Abreo, F., Ampil, F., Sanders, M., Burton, G. V., Li, B., Chu, Q. (2007). Overexpression of chemokine receptor CXCR4 in cancer specimens following neoadjuvant chemotherapy predicts outcome in patients with locally advanced breast cancer (LABC). J. Clin. Oncol. (Meeting Abstracts), 25, 10578.
- Hu, H., Shioda, T., Hori, T., Moriya, C., Kato, A., Sakai, Y., Matsushima, K., Uchiyama, T., Nagai, Y. (1998). Dissociation of ligand-induced internalization of CXCR-4 from its co-receptor activity for HIV-1 Env-mediated membrane fusion. Arch. Virol., 143(5), 851-861.
- Kahn, J., Byk, T., Jansson-Sjostrand, L., Petit, I., Shivtiel, S., Nagler, A., Hardan, I., Deutsch, V., Gazit, Z., Gazit, D., Karlsson, S., Lapidot, T. (2004). Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation. Blood, 103(8), 2942-2949.
- Kalinkovich, A., Tavor, S., Avigdor, A., Kahn, J., Brill, A., Petit, I., Goichberg, P., Tesio, M., Netzer, N., Naparstek, E., Hardan, I., Nagler, A., Resnick, I., Tsimanis, A., Lapidot T. (2006). Functional CXCR4-expressing microparticles and SDF-1 correlate with circulating acute myelogenous leukemia cells. Cancer Res., 66(22), 11013-11020.
- Kato, M., Kitayama, J., Kazama, S., Nagawa, H. (2003). Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res., 5(5), R144-R150.
- Loetscher, M., Geiser, T., O'Reilly, T., Zwahlen, R., Baggiolini, M., Moser, B. (1994). Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J. Biol. Chem., 269(1), 232-237.
- Moser, B., Barella, L., Mattei, S., Schumacher, C., Boulay, F., Colombo, M. P., Baggiolini, M. (1993). Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cells. Biochem. J., 294(Pt 1), 285-292.
- Murphy, B., Boynton, A. L., Sehgal, A. (2005). United States Patent 6863887. Washington D. C.: U. S. Patent and Trademark Office.
- Nagasawa, T., Tachibana K., Kawabata K. (1999). A CXC chemokine SDF-1/PBSF: A ligand for a HIV coreceptor, CXCR4. Adv. Immunol., 71, 211-228.
- Schrader, A. J., Lechner, O., Templin, M., Dittmar, K. E., Machtens, S., Mengel, M., Probst-Kepper, M., Franzke, A., Wollensak, T., Gatzlaff, P., Atzpodien, J., Buer, J., Lauber J. (2002). CXCR4/CXCL12 expression and signalling in kidney cancer. Brit. J. Cancer, 86(8), 1250-1256.
- Tsutsumi, H., Tanaka, T., Ohashi, N., Masuno, H., Tamamura, H., Hiramatsu, K., Araki, T., Ueda, S., Oishi, S., Fujii, N. (2007). Therapeutic potential of the chemokine receptor CXCR4 antagonists as multifunctional agents. Biopolymers, 88(2), 279-289.
- Wegner, S. A., Ehrenberg, P. K., Chang, G., Dayhoff, D. E., Sleeker, A. L., Michael, N. L. (1998). Genomic organization and functional characterization of the chemokine receptor CXCR4, a major entry co-receptor for human immunodeficiency virus type 1. J. Biol. Chem., 273(8), 4754-4760.
- Xu, C., Sui, J., Tao, H., Zhu, Q., Marasco, W. A. (2007). Human anti-CXCR4 antibodies undergo VH replacement, exhibit functional V-region sulfation, and define CXCR4 antigenic heterogeneity. J. Immunol., 179(4), 2408-2418.
- Zamarchi, R., Allavena, P., Borsetti, A., Stievano, L., Tosello, V., Marcato, N., Esposito, G., Roni, V., Paganin, C., Bianchi, G., Titti, F., Verani, P., Gerosa, G., Amadori, A. (2002). Expression and functional activity of CXCR-4 and CCR-5 chemokine receptors in human thymocytes. Clin. Exp. Immunol., 127(2), 321-330.